moffitt cancer center

Researchers find ovarian cancer risk related to inherited inflam...

EurekAlert! - Cancer  Mon, 02/06/2012 - 23:00

(H. Lee Moffitt Cancer Center & Research Institute) In a study conducted by researchers at Moffitt Cancer Center and colleagues from 11 other institutions in the Unites States and the United Kingdom, genes that are known to be involved in inflammation were found to be related to risk of ovarian cancer.


 

Researchers find new, noninvasive way to identify lymph node met...

EurekAlert! - Cancer  Wed, 01/11/2012 - 23:00

(H. Lee Moffitt Cancer Center & Research Institute) Using two cell surface markers found to be highly expressed in breast cancer lymph node metastases, researchers at Moffitt Cancer Center, working with colleagues at other institutions, have developed targeted, fluorescent molecular imaging probes that can noninvasively detect breast cancer lymph node metastases.

The new procedure could spare breast cancer patients invasive and unreliable sentinel lymph node biopsies and surgery-associated negative side effects.


 

Researchers find smoking is strongly associated with squamous ce...

EurekAlert! - Cancer  Wed, 12/07/2011 - 23:00

(H. Lee Moffitt Cancer Center & Research Institute) Women who have non-melanoma skin cancers are more likely to have smoked cigarettes compared to women without skin cancer, said researchers at Moffitt Cancer Center in Tampa, Fla., who published study results in a recent issue of Cancer Causes & Control.


 

Moffitt researchers will be strong participants in American Soci...

EurekAlert! - Cancer  Sun, 12/04/2011 - 23:00

(H. Lee Moffitt Cancer Center & Research Institute) When the American Society of Hematology convenes its 53rd Annual Meeting and Exposition on Dec. 10-13 in San Diego, Calif., researchers from Moffitt Cancer Center will break a new record for Moffitt participants with one plenary presentation, 16 oral presentations and more than 50 poster presentations on new research results in a variety of meeting programs that focus on blood cancer basic science and clinical applications, including bone marrow transplantation and clinical trials results.


 

Follow-up study finds prolonged fatigue for those who had chemot...

EurekAlert! - Cancer  Sun, 12/04/2011 - 23:00

(H. Lee Moffitt Cancer Center & Research Institute) In a follow-up study, researchers at Moffitt Cancer Center and colleagues have found that patients who receive chemotherapy for breast cancer might experience prolonged fatigue years after their therapy.

The new study, published in the American Cancer Society's current issue of CANCER, is a follow-up to a study on fatigue and chemotherapy and radiotherapy for breast cancer Moffitt researchers published in CANCER in 2007.


 

Moffitt Cancer Center researchers find more clues to causes of b...

EurekAlert! - Cancer  Wed, 10/26/2011 - 22:00

(H. Lee Moffitt Cancer Center & Research Institute) Publishing in the current issue of the Journal of Biological Chemistry, researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism -- inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) -- could be targeted as a therapeutic intervention for treating cancer.


 

Scientists identify a key molecule that blocks abnormal blood ve...

EurekAlert! - Cancer  Tue, 09/20/2011 - 22:00

(H. Lee Moffitt Cancer Center & Research Institute) A new and better understanding of blood vessel growth and vascular development (angiogenesis) in cancer has been made possible by research carried out by a team of scientists from Moffitt Cancer Center, the University of Florida, Harvard University, Yale University and the Children's Hospital of Los Angeles.


 

Moffitt Cancer Center researchers use new tool to counter multip...

EurekAlert! - Cancer  Thu, 09/08/2011 - 22:00

(H. Lee Moffitt Cancer Center & Research Institute) Moffitt Cancer Center researchers, and colleagues, are pioneering promising research utilizing a monitoring technology that could provide a better understanding of acquired drug resistance and assist in clinical decision-making for developing individualized patient treatments for multiple myeloma.


 

Scripps Research wins more than $2 million to study prostate can...

EurekAlert! - Cancer  Mon, 04/25/2011 - 22:00

(Scripps Research Institute) The Scripps Research Institute and Tampa's Moffitt Cancer Center have been awarded more than $2 million to study the formation and progression of prostate cancer.

Of the funds awarded, approximately $1.9 million will go to Scripps Research, with the remaining $138,380 supporting Moffitt Cancer Center work.


 

Moffitt Cancer Center: Growing interest in prognostic test for n...

EurekAlert! - Cancer  Sun, 04/25/2010 - 22:00

(H. Lee Moffitt Cancer Center & Research Institute) Moffitt Cancer Center announces steadily growing interest in the ERCC1 Analysis, the first test developed for selecting chemotherapy for Non Small Lung Cancer patients.

Each year, more than 200,000 Americans are diagnosed with lung cancer.